Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
700 people get BCR articles and Market Currents by email alert.
Get email alerts on BCR »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
Business Wire (May 3, 2013)
-
Business Wire (Apr 23, 2013)
-
Business Wire (Apr 17, 2013)
-
Business Wire (Apr 8, 2013)
-
Business Wire (Mar 6, 2013)
-
Business Wire (Feb 25, 2013)
-
Business Wire (Feb 14, 2013)
-
Business Wire (Jan 31, 2013)
To learn more about Seeking Alpha Pro, click here.
-
This Bard's Tale Still Worth HearingStephen Simpson • Thu, Jan 12, 2012
-
C.R. Bard: Earnings PreviewZacks Investment Research • Mon, Oct 24, 2011
-
We Are Putting C.R. Bard On Our Buy ListAll American Investor • Thu, Oct 20, 2011
-
C.R. Bard Issues Upbeat FY 2011 OutlookZacks Investment Research • Thu, Dec 16, 2010
-
Considering C.R. Bard's Long Term ValueBud Labitan • Mon, Jun 21, 2010
-
Future Hospital Revenue Boom Benefits CR BardTodd Campbell • Tue, Sep 15, 2009
-
C.R. Bard: Going for GrowthVahan Janjigian • Mon, Jan 12, 2009
-
Should Med Tech Head For The Dunes?Stephen Simpson • Thu, Jan 3
-
Top 5 Stocks With Insider Sells Filed On October 3 To ConsiderMarkus Aarnio • Thu, Oct 4, 2012
-
The 6 Best Seasonal Large Cap Healthcare Stocks To Own Through NovemberTodd Campbell • Tue, Sep 11, 2012
-
CR Bard Management Discusses Q3 2012 Results - Earnings Call TranscriptTue, Oct 23, 2012 • 1 Comment
-
CR Bard Management Discusses Q2 2012 Results - Earnings Call TranscriptWed, Jul 25, 2012
-
CR Bard's CEO Discusses Q1 2012 Results - Earnings Call TranscriptWed, Apr 25, 2012
-
CR Bard's CEO Discusses Q4 2011 Results - Earnings Call TranscriptTue, Jan 31, 2012
-
CR Bard Inc., 2012 Guidance/Update Call, Dec 20, 2011Wed, Dec 21, 2011
-
CR Bard's CEO Discusses Q3 2011 Results - Earnings Call TranscriptWed, Oct 26, 2011
-
CR Bard's CEO Discusses Q2 2011 Results - Earnings Call TranscriptFri, Jul 22, 2011
-
CR Bard's CEO Discusses Q1 2011 Results - Earnings Call TranscriptFri, Apr 22, 2011
-
CR Bard's CEO Discusses Q4 2010 Results - Earnings Call TranscriptTue, Feb 1, 2011
-
CR Bard Inc. CEO Discusses Q3 2010 Results - Earnings Call TranscriptFri, Oct 22, 2010
-
CR Bard Inc. Q2 2010 Earnings Call TranscriptThu, Jul 22, 2010
-
C. R. Bard, Inc. Q1 2010 Earnings Call TranscriptThu, Apr 22, 2010
-
CR Bard Inc. Q4 2009 Earnings Call TranscriptFri, Jan 29, 2010
-
CR Bard, Inc Q3 2009 Earnings Call TranscriptWed, Oct 21, 2009
-
CR Bard Q2 2009 Earnings Call TranscriptWed, Jul 22, 2009
-
C.R. Bard, Inc. Q1 2009 Earnings Call TranscriptThu, Apr 23, 2009
-
Business Wire (May 3, 2013)
-
Business Wire (Apr 23, 2013)
-
Business Wire (Apr 17, 2013)
-
Business Wire (Apr 8, 2013)
-
Business Wire (Mar 6, 2013)
-
Business Wire (Feb 25, 2013)
-
Business Wire (Feb 14, 2013)
-
Business Wire (Jan 31, 2013)
-
Business Wire (Jan 7, 2013)
-
Business Wire (Dec 21, 2012)
-
at MarketWatch.com (Dec 21, 2012)
-
Business Wire (Dec 12, 2012)
-
at Fox Business (Nov 28, 2012)
-
Business Wire (Oct 23, 2012)
-
Business Wire (Oct 23, 2012)
-
at MarketWatch.com (Oct 23, 2012)
-
Business Wire (Oct 10, 2012)
-
Business Wire (Oct 1, 2012)
-
Business Wire (Jul 25, 2012)
BCR vs. ETF Alternatives
Company Description
C. R. Bard, Inc. and its subsidiaries (the “company” or “Bard”) are engaged in the design, manufacture, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. Charles Russell Bard founded the company in 1907. In 1923, the company was incorporated as C. R.... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Tuesday, April 23, 4:15 PM C.R. Bard (BCR): Q1 EPS of $1.44 beats by $0.02. Revenue of $740.3M (+1% Y/Y) beats by $11.85M. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Tuesday, April 23, 12:10 AM Notable earnings after Tuesday’s close: AAPL, ACC, AMGN, AWAY, BCR, BRCM, CREE, DV, EW, FBC, FTI, HA, HBI, HLIT, HTS, IRBT, ITC, JNPR, LIFE, NBR, NFX, NSC, OI, OII, OMI, PACB, PLCM, PNRA, RFMD, RHI, T, UIS, USNA, VMW, WRB, YUM, ZIXI Comment! [Earnings]
- Monday, April 22, 5:35 PM Notable earnings after Tuesday’s close: AAPL, ACC, AMGN, AWAY, BCR, BRCM, CREE, DV, EW, FBC, FTI, HA, HBI, HLIT, HTS, IRBT, ITC, JNPR, LIFE, NBR, NFX, NSC, OI, OII, OMI, PACB, PLCM, PNRA, RFMD, RHI, T, UIS, USNA, VMW, WRB, YUM, ZIXI Comment! [Earnings]
- Wednesday, April 17, 5:17 PM C.R. Bard, Inc. (BCR) declares $0.20/share quarterly dividend, in line with previous. Forward yield 0.79%. For shareholders of record Apr. 29. Payable May 10. Ex-div date Apr. 25. (PR) Comment! [Dividends]
- Tuesday, February 26, 10:03 AM The award of $3.35M against J&J (JNJ +0.8%) over its vaginal mesh in a case involving a South Dakota patient could have an impact on other suits against the company and rival manufacturers C.R. Bard (BCR +0.3%), Boston Scientific (BSX -0.3%) and Endo Health (ENDP +0.3%). Around 11,000 claims have been consolidated into five cases that are pending in West Virginia. Comment! [Healthcare]
- Thursday, January 31, 4:06 PM C.R. Bard (BCR): Q4 EPS of $1.7 beats by $0.03. Revenue of $762.6M (+1% Y/Y) beats by $. Shares -3.4% AH. (PR) Comment! [Earnings, Breaking News, Healthcare, On the Move]
- Thursday, January 31, 12:10 AM Notable earnings after Thursday’s close: AFFX, BCR, BKH, CAVM, CB, CTCT, CTRP, ED, EMN, FBHS, GDOT, MCK, MIPS, MITK, MTW, N, NGVC, PFG, PMCS, PWER, SPF, TLAB, TSYS, WYNN, ZOLT Comment! [Earnings]
- Wednesday, January 30, 5:35 PM Notable earnings after Thursday’s close: AFFX, BCR, BKH, CAVM, CB, CTCT, CTRP, ED, EMN, FBHS, GDOT, MCK, MIPS, MITK, MTW, N, NGVC, PFG, PMCS, PWER, SPF, TLAB, TSYS, WYNN, ZOLT Comment! [Earnings]
- Wednesday, October 24, 2012, 12:51 PM Medical-device firm C.R. Bard (BCR -2.5%) dips on a mixed Q3, with net profit roughly flat Y/Y as sales rose less than expected. The company blames the shortfall on a weakness in its U.S. market, where sales fell roughly 1%. Sales were stronger abroad, rising about 3%. Sales in its vascular business, its largest, were down 2.7%, while its urology unit posted a 3.2% rise. The company also announced plans to acquire privately held Neomend, a developer of sprayable surgical sealants and anti-adhesion products, for $140M. Comment! [Healthcare, Earnings, On the Move]
- Tuesday, October 23, 2012, 4:29 PM C.R. Bard (BCR): Q3 EPS of $1.64 beats by $0.01. Revenue of $722.9M (+1% Y/Y) misses by $12M. (PR) Comment! [Earnings, Healthcare]
- Tuesday, October 23, 2012, 12:10 AM Notable earnings after Tuesday’s close: ACE, AFL, ALTR, AMGN, BCR, BNNY, BRCM, BWLD, CBI, CHRW, FB, FBC, FBHS, FTI, GILD, HTS, ILMN, INVN, IRBT, JNPR, NBR, NFLX, NFX, NSC, PLCM, PNRA, QCOR, RFMD, STM, TPX, TSS, UIS, VMW, WYNN Comment! [Earnings]
- Monday, October 22, 2012, 5:35 PM Notable earnings after Tuesday’s close: ACE, AFL, ALTR, AMGN, BCR, BNNY, BRCM, BWLD, CBI, CHRW, FB, FBC, FBHS, FTI, GILD, HTS, ILMN, INVN, IRBT, JNPR, NBR, NFLX, NFX, NSC, PLCM, PNRA, QCOR, RFMD, STM, TPX, TSS, UIS, VMW, WYNN Comment! [Earnings]
- Wednesday, October 10, 2012, 4:14 PM C.R. Bard (BCR) declares $0.20/share quarterly dividend, in line with previous. Forward yield 0.78%. For shareholders of record Oct 22. Payable Nov 02. Ex-div date Oct 18. (PR) Comment! [Dividends]
- Wednesday, July 25, 2012, 4:22 PM C.R. Bard (BCR): Q2 EPS of $1.62 misses by $0.01. Revenue of $742.6M (+2% Y/Y) misses by $11.25M. (PR) Comment! [Earnings, Healthcare]
- Wednesday, July 25, 2012, 12:10 AM Notable earnings after Wednesday's close: AEM, AKAM, AMP, AVB, BCR, CCI, CDNS, CLF, CMO, CROX, CTXS, CYH, DRE, EQR, FLEX, FTNT, ISIL, KBR, LRCX, LSI, LVS, OI, OII, ORLY, STR, SUSQ, SYMC, TER, TEX, TSCO, TSLA, V, VAR, WDC, WFM, WLL, ZNGA Comment! [Earnings]
- Tuesday, July 24, 2012, 5:35 PM Notable earnings after Wednesday's close: AEM, AKAM, AMP, AVB, BCR, CCI, CDNS, CLF, CMO, CROX, CTXS, CYH, DRE, EQR, FLEX, FTNT, ISIL, KBR, LRCX, LSI, LVS, OI, OII, ORLY, STR, SUSQ, SYMC, TER, TEX, TSCO, TSLA, V, VAR, WDC, WFM, WLL, ZNGA 1 Comment [Earnings]
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.









